Learn · Part 5. Special situations · 4 min read
Kidney disease and contrast
Iodinated and gadolinium contrast in reduced kidney function, which tests avoid contrast, and the one number the sources give.
60-second take
- Iodinated contrast (CCTA, angiography) risks kidney injury. Gadolinium (CMR) risks nephrogenic systemic sclerosis and retention.
- The only kidney-function cut-off in the sources is GFR below 30 mL/min/1.73 m2 as a contraindication to stress CMR. For CCTA, the chest pain guideline leaves the threshold to local protocols.
- Stress SPECT and PET do not use these contrast agents, and vasodilator stressors can be used in CKD and end-stage kidney disease.
- To limit contrast injury: avoid other kidney-toxic drugs, hydrate before iodinated contrast, and use the least contrast needed.
- For patients on dialysis, schedule stress testing away from the period just after a session when possible.
Two contrast agents, two different worries
Two kinds of contrast matter for heart testing. Iodinated contrast is used for coronary CT angiography (CCTA) and invasive angiography. The worry is injury to the kidney. Gadolinium-based contrast agents (GBCAs) are used in cardiac MRI (CMR) for perfusion and scar imaging. The worries are nephrogenic systemic sclerosis (NSF) and gadolinium retention in the brain, both of which have led to regulatory action .
Exercise ECG, and stress SPECT and PET, do not use either of these contrast agents; they rely on the heart’s own response to stress and on a radioactive tracer. So kidney function shapes the choice most for CCTA, invasive angiography and CMR.
What the sources say, test by test
| Test | Kidney disease in the sources |
|---|---|
| Stress CMR (gadolinium) | The chest pain guideline lists reduced GFR below 30 mL/min/1.73 m² among the contraindications to stress CMR . The SCMR protocol document asks for the lowest gadolinium dose that gives adequate images, attention to each agent’s retention characteristics (especially in patients at higher risk of retention or NSF), and noncontrast techniques as alternatives whenever possible . |
| CCTA (iodinated) | The same table lists renal impairment for CCTA but leaves the definition to local protocols. It gives no number . |
| Invasive angiography and PCI (iodinated) | For patients with chronic coronary disease and chronic kidney disease (CKD), the guideline says to take measures to lower the risk of treatment-related acute kidney injury. When PCI is clinically needed, fear of contrast-induced kidney injury should not be a reason to withhold it in most patients with CKD . |
| Stress echo | The ASE guideline notes that gadolinium for CMR may be undesirable, especially in kidney disease, and lists the absence of radiation or gadolinium as part of echo’s appeal . |
| Stress SPECT and PET | Vasodilator stress is the most used stressor in this group, because exercise is often not feasible. Adenosine, dipyridamole and regadenoson can all be used in CKD and end-stage kidney disease. Exercise is still generally preferred when it is feasible. In one study of patients with kidney failure, regadenoson caused more nausea and diarrhea and more aminophylline use than in controls with preserved kidney function, without a significant rise in serious adverse events . |
About the numbers
The only kidney-function cut-off for contrast in the sources we cite here is a GFR below 30 mL/min/1.73 m², listed as a contraindication to stress CMR. For CCTA, the guideline leaves the threshold to local protocols, so the right eGFR cut-off is whatever your imaging lab uses. The scenario builder matches this: it flags gadolinium as a contraindication below 30 and shows caution with iodinated contrast when kidney function is reduced.
Minimizing harm when iodinated contrast is needed
The chronic coronary disease guideline describes these steps: avoid other kidney-toxic drugs where possible, give adequate hydration before iodinated contrast, and use the smallest contrast volume that works. It adds that high-dose statins may reduce contrast-induced injury, and that bicarbonate or N-acetylcysteine offer no advantage over normal saline.
Dialysis and the timing of testing
For people on chronic dialysis, the ASNC stress guideline points to shifts in fluid and electrolytes around dialysis. When possible, stress testing should be scheduled to avoid the period right after a session, though the timing should be individualized to the patient and the site . For people who have missed sessions, or whose electrolytes are changing quickly, it is reasonable to check electrolytes before stress testing .
Noninvasive tests may be less accurate in CKD
People with CKD often have more advanced coronary atherosclerosis, and the 2023 guideline notes that noninvasive diagnostic testing is often less accurate in this group . The guideline suggests that a team-based approach, with both cardiac and kidney teams and shared decision-making, would be beneficial.
The documents we reviewed give no eGFR cut-off for CCTA, and no dosing or timing rules for gadolinium in dialysis patients beyond the cautions above. The SCCT consensus mentions renal dysfunction when it prefers transesophageal echo to CT for left atrial appendage questions, but that concerns a different clinical question from coronary disease, so we have not applied it here .
Premedication, hydration protocols for specific eGFR bands, and rules for macrocyclic versus linear gadolinium are decisions for your local radiology and nephrology teams. The sources we were given do not set them out.
Open the scenario builder → and enter reduced kidney function or dialysis as a patient factor to see which tests are flagged for contrast.
Try it in the tool
Sources cited on this page
Click a tag for the full reference. All references